initial publishing

Pseudo-Lab · Sep 18, 2023 · 0fe12a7 · 0fe12a7
1 parent 998d5da
commit 0fe12a7
Show file tree

Hide file tree

Showing 25 changed files with 286 additions and 258 deletions.
diff --git a/_sources/docs/Delta_part1.md b/_sources/docs/Delta_part1.md
@@ -1,6 +1,4 @@
-# 
-
-# **DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomized controlled trial 리뷰**
+# DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomized controlled trial part 1
 
 https://lh4.googleusercontent.com/pno7K44oyUgCTg8M6IuAgTSCyqV_GWwY1Cx8Oky6SMjnzEgzQlLYdtP3wmXBmjnLOttizR_SfRkzN6T6mUumMsJDvsBlhFmfW8o0mZnuFJ8qiCD_57m-8NDlrzAEeStdHL64lusoLoBWIP7t1jdtHbk
 

diff --git a/_sources/docs/Diagnostic_part1.md b/_sources/docs/Diagnostic_part1.md
@@ -1,4 +1,4 @@
-# 
+# Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests - Guidance for Industry and FDA Staff part 1
 
 **진단 검사를 평가하는 연구 결과의 보고에 대한 통계적 지침**
 

diff --git a/_sources/docs/Diagnostic_part2.md b/_sources/docs/Diagnostic_part2.md
@@ -1,4 +1,4 @@
-# ****Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests - Guidance for Industry and FDA Staff****
+# Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests - Guidance for Industry and FDA Staff part 2
 
 # 5. Reporting Recommendations : 권장사항 보고
 

diff --git a/_sources/docs/E9R1_part1.md b/_sources/docs/E9R1_part1.md
@@ -1,4 +1,4 @@
-# E9(R1) STATISTICAL PRINCIPLES FOR CLINICAL TRIALS: ADDENDUM: ESTIMANDS AND SENSITIVITY ANALYSIS IN CLINICAL TRIALS
+# E9(R1) STATISTICAL PRINCIPLES FOR CLINICAL TRIALS: ADDENDUM: ESTIMANDS AND SENSITIVITY ANALYSIS IN CLINICAL TRIALS part 1
 
 # 1. PURPOSE AND SCOPE (A.1)
 

diff --git a/_sources/docs/E9R1_part2.md b/_sources/docs/E9R1_part2.md
@@ -1,4 +1,4 @@
-# E9(R1) STATISTICAL PRINCIPLES FOR CLINICAL TRIALS: ADDENDUM: ESTIMANDS AND SENSITIVITY ANALYSIS IN CLINICAL TRIALS
+# E9(R1) STATISTICAL PRINCIPLES FOR CLINICAL TRIALS: ADDENDUM: ESTIMANDS AND SENSITIVITY ANALYSIS IN CLINICAL TRIALS part 2
 
 # 4. IMPACT ON TRIAL DESIGN AND CONDUCT
 

diff --git a/_sources/docs/E9_part1.md b/_sources/docs/E9_part1.md
@@ -1,6 +1,5 @@
----
-title: "Guideline for Industry E9 Statistical Principles for Clinical Trials"
----
+## Guideline for Industry E9 Statistical Principles for Clinical Trials part 1
+
 
 # 1. INTRODUCTION
 

diff --git a/_sources/docs/E9_part2.md b/_sources/docs/E9_part2.md
@@ -1,3 +1,5 @@
+## Guideline for Industry E9 Statistical Principles for Clinical Trials part 2
+
 # 5. Data Analysis Considerations
 
 Statistical Analysis Plan (SAP, 통계분석계획서)는 프로토콜이 완성되고나서 작성되어야 한다. 그리고 blind review가 끝나고 다시 검토되어야 한다.

diff --git a/_sources/docs/GCP_part1.md b/_sources/docs/GCP_part1.md
@@ -1,8 +1,4 @@
----
-title: "GCP E6_R2 Part1"
----
-
-## Good Clinical Practice (GCP)
+## Good Clinical Practice (GCP) part 1
 
 GCP의 목적은 두 가지이다. 첫째는 시험자를 보호하는 것 (human subject protection)이고, 신뢰할 수 있는 임상시험 결과(reliability of trial results)를 만드는 것이다 (2.13.).
 

diff --git a/_sources/docs/GCP_part2.md b/_sources/docs/GCP_part2.md
@@ -1,6 +1,4 @@
----
-title: "GCP E6_R2 Part2"
----
+## Good Clinical Practice (GCP) part 2
 
 목차
 

diff --git a/docs/Delta_part1.html b/docs/Delta_part1.html
@@ -9,7 +9,7 @@
     <meta charset="utf-8" />
     <meta name="viewport" content="width=device-width, initial-scale=1.0" /><meta name="generator" content="Docutils 0.18.1: http://docutils.sourceforge.net/" />
 
-    <title> &#8212; PseudoLab [Let-Biostat-Guidance-Guide-Us]</title>
+    <title>DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomized controlled trial part 1 &#8212; PseudoLab [Let-Biostat-Guidance-Guide-Us]</title>
 
 
 
@@ -158,42 +158,44 @@
             </li>
         </ul>
         <ul class="current nav bd-sidenav">
-<li class="toctree-l1"><a class="reference internal" href="GCP_part1.html">Good Clinical Practice (GCP)</a></li>
+<li class="toctree-l1"><a class="reference internal" href="GCP_part1.html">Good Clinical Practice (GCP) part 1</a></li>
 
 
 
-<li class="toctree-l1"><a class="reference internal" href="GCP_part2.html">6. Clinical trial protocol and protocol amendment(s)</a></li>
+<li class="toctree-l1"><a class="reference internal" href="GCP_part2.html">Good Clinical Practice (GCP) part 2</a></li>
 
 
 
-<li class="toctree-l1"><a class="reference internal" href="E9_part1.html">1. INTRODUCTION</a></li>
 
+<li class="toctree-l1"><a class="reference internal" href="E9_part1.html">Guideline for Industry E9 Statistical Principles for Clinical Trials part 1</a></li>
 
 
-<li class="toctree-l1"><a class="reference internal" href="E9_part2.html">5. Data Analysis Considerations</a></li>
 
 
-<li class="toctree-l1"><a class="reference internal" href="Switching.html">Points to Consider on Switching between Superiority and Non-inferiority</a></li>
+<li class="toctree-l1"><a class="reference internal" href="E9_part2.html">Guideline for Industry E9 Statistical Principles for Clinical Trials part 2</a></li>
+
+
 
+<li class="toctree-l1"><a class="reference internal" href="Switching.html">Points to Consider on Switching between Superiority and Non-inferiority</a></li>
 
 
 
 
 
 
-<li class="toctree-l1 current active"><a class="current reference internal" href="#"></a></li>
 
+<li class="toctree-l1 current active"><a class="current reference internal" href="#">DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomized controlled trial part 1</a></li>
 <li class="toctree-l1"><a class="reference internal" href="Delta_part2.html">DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial part2</a></li>
-<li class="toctree-l1"><a class="reference internal" href="Diagnostic_part1.html"></a></li>
-<li class="toctree-l1"><a class="reference internal" href="Diagnostic_part2.html"><strong><strong>Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests - Guidance for Industry and FDA Staff</strong></strong></a></li>
+<li class="toctree-l1"><a class="reference internal" href="Diagnostic_part1.html">Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests - Guidance for Industry and FDA Staff part 1</a></li>
+<li class="toctree-l1"><a class="reference internal" href="Diagnostic_part2.html">Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests - Guidance for Industry and FDA Staff part 2</a></li>
 
 
 
-<li class="toctree-l1"><a class="reference internal" href="E9R1_part1.html">E9(R1) STATISTICAL PRINCIPLES FOR CLINICAL TRIALS: ADDENDUM: ESTIMANDS AND SENSITIVITY ANALYSIS IN CLINICAL TRIALS</a></li>
+<li class="toctree-l1"><a class="reference internal" href="E9R1_part1.html">E9(R1) STATISTICAL PRINCIPLES FOR CLINICAL TRIALS: ADDENDUM: ESTIMANDS AND SENSITIVITY ANALYSIS IN CLINICAL TRIALS part 1</a></li>
 
 
 
-<li class="toctree-l1"><a class="reference internal" href="E9R1_part2.html">E9(R1) STATISTICAL PRINCIPLES FOR CLINICAL TRIALS: ADDENDUM: ESTIMANDS AND SENSITIVITY ANALYSIS IN CLINICAL TRIALS</a></li>
+<li class="toctree-l1"><a class="reference internal" href="E9R1_part2.html">E9(R1) STATISTICAL PRINCIPLES FOR CLINICAL TRIALS: ADDENDUM: ESTIMANDS AND SENSITIVITY ANALYSIS IN CLINICAL TRIALS part 2</a></li>
 
 
 
@@ -380,7 +382,7 @@
 
 
 <div id="jb-print-docs-body" class="onlyprint">
-    <h1></h1>
+    <h1>DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomized controlled trial part 1</h1>
     <!-- Table of contents -->
     <div id="print-main-content">
         <div id="jb-print-toc">
@@ -390,18 +392,13 @@ <h2> Contents </h2>
             </div>
             <nav aria-label="Page">
                 <ul class="visible nav section-nav flex-column">
-<li class="toc-h1 nav-item toc-entry"><a class="reference internal nav-link" href="#"></a></li>
-<li class="toc-h1 nav-item toc-entry"><a class="reference internal nav-link" href="#delta2-guidance-on-choosing-the-target-difference-and-undertaking-and-reporting-the-sample-size-calculation-for-a-randomized-controlled-trial"><strong>DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomized controlled trial 리뷰</strong></a><ul class="visible nav section-nav flex-column">
 <li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#information"><strong>Information</strong></a></li>
-<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#id2"><strong>논문 소개</strong></a></li>
+<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#id1"><strong>논문 소개</strong></a></li>
 <li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#the-delta2-project"><strong>The DELTA2 project</strong></a></li>
 <li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#box-1-delta2-recommendations-for-researchers-undertaking-a-sample-size-calculation-and-choosing-the-target-difference"><strong>Box 1: DELTA2 recommendations for researchers undertaking a sample size calculation and choosing the target difference</strong></a></li>
 <li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#the-target-difference-and-sample-size-calculations-in-randomised-controlled-trials"><strong>The target difference and sample size calculations in randomised controlled trials</strong></a></li>
 <li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#rct"><strong>RCT 연구에서의 목표 차이값과 표본수 산출</strong></a></li>
 </ul>
-</li>
-</ul>
-
             </nav>
         </div>
     </div>
@@ -412,11 +409,8 @@ <h2> Contents </h2>
 <div id="searchbox"></div>
                 <article class="bd-article" role="main">
 
-  <section class="tex2jax_ignore mathjax_ignore" id="id1">
-<h1><a class="headerlink" href="#id1" title="Permalink to this heading">#</a></h1>
-</section>
-<section class="tex2jax_ignore mathjax_ignore" id="delta2-guidance-on-choosing-the-target-difference-and-undertaking-and-reporting-the-sample-size-calculation-for-a-randomized-controlled-trial">
-<h1><strong>DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomized controlled trial 리뷰</strong><a class="headerlink" href="#delta2-guidance-on-choosing-the-target-difference-and-undertaking-and-reporting-the-sample-size-calculation-for-a-randomized-controlled-trial" title="Permalink to this heading">#</a></h1>
+  <section class="tex2jax_ignore mathjax_ignore" id="delta2-guidance-on-choosing-the-target-difference-and-undertaking-and-reporting-the-sample-size-calculation-for-a-randomized-controlled-trial-part-1">
+<h1>DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomized controlled trial part 1<a class="headerlink" href="#delta2-guidance-on-choosing-the-target-difference-and-undertaking-and-reporting-the-sample-size-calculation-for-a-randomized-controlled-trial-part-1" title="Permalink to this heading">#</a></h1>
 <p><a class="reference external" href="https://lh4.googleusercontent.com/pno7K44oyUgCTg8M6IuAgTSCyqV_GWwY1Cx8Oky6SMjnzEgzQlLYdtP3wmXBmjnLOttizR_SfRkzN6T6mUumMsJDvsBlhFmfW8o0mZnuFJ8qiCD_57m-8NDlrzAEeStdHL64lusoLoBWIP7t1jdtHbk">https://lh4.googleusercontent.com/pno7K44oyUgCTg8M6IuAgTSCyqV_GWwY1Cx8Oky6SMjnzEgzQlLYdtP3wmXBmjnLOttizR_SfRkzN6T6mUumMsJDvsBlhFmfW8o0mZnuFJ8qiCD_57m-8NDlrzAEeStdHL64lusoLoBWIP7t1jdtHbk</a></p>
 <p><strong>2023년 07월 31일</strong></p>
 <section id="information">
@@ -434,8 +428,8 @@ <h2><strong>Information</strong><a class="headerlink" href="#information" title=
 </li>
 </ul>
 </section>
-<section id="id2">
-<h2><strong>논문 소개</strong><a class="headerlink" href="#id2" title="Permalink to this heading">#</a></h2>
+<section id="id1">
+<h2><strong>논문 소개</strong><a class="headerlink" href="#id1" title="Permalink to this heading">#</a></h2>
 <p>DELTA2 Guidance는 RCT(Randomised Clinical Trial) 임상 연구에서 목표하는 차이값(target difference)과 이에 따라 계산되는 표본 수 산출(sample size calculation)에 대한 Guidance로 University of Oxford의 Centre for Statistics in Medicine 에서 2019년에 최종 버전이 발표되었습니다.</p>
 <p>이 논문에서는 이 Guidance의 주요 내용(target difference 설정 및 표본수 산출)에 대해 설명하고 있습니다.</p>
 </section>
@@ -824,18 +818,13 @@ <h2><strong>RCT 연구에서의 목표 차이값과 표본수 산출</strong><a
   </div>
   <nav class="bd-toc-nav page-toc">
     <ul class="visible nav section-nav flex-column">
-<li class="toc-h1 nav-item toc-entry"><a class="reference internal nav-link" href="#"></a></li>
-<li class="toc-h1 nav-item toc-entry"><a class="reference internal nav-link" href="#delta2-guidance-on-choosing-the-target-difference-and-undertaking-and-reporting-the-sample-size-calculation-for-a-randomized-controlled-trial"><strong>DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomized controlled trial 리뷰</strong></a><ul class="visible nav section-nav flex-column">
 <li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#information"><strong>Information</strong></a></li>
-<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#id2"><strong>논문 소개</strong></a></li>
+<li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#id1"><strong>논문 소개</strong></a></li>
 <li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#the-delta2-project"><strong>The DELTA2 project</strong></a></li>
 <li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#box-1-delta2-recommendations-for-researchers-undertaking-a-sample-size-calculation-and-choosing-the-target-difference"><strong>Box 1: DELTA2 recommendations for researchers undertaking a sample size calculation and choosing the target difference</strong></a></li>
 <li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#the-target-difference-and-sample-size-calculations-in-randomised-controlled-trials"><strong>The target difference and sample size calculations in randomised controlled trials</strong></a></li>
 <li class="toc-h2 nav-item toc-entry"><a class="reference internal nav-link" href="#rct"><strong>RCT 연구에서의 목표 차이값과 표본수 산출</strong></a></li>
 </ul>
-</li>
-</ul>
-
   </nav></div>
 
 </div></div>

diff --git a/docs/Delta_part2.html b/docs/Delta_part2.html
@@ -67,8 +67,8 @@
     <link rel="shortcut icon" href="../_static/PseudoLab_logo.png"/>
     <link rel="index" title="Index" href="../genindex.html" />
     <link rel="search" title="Search" href="../search.html" />
-    <link rel="next" title="" href="Diagnostic_part1.html" />
-    <link rel="prev" title="" href="Delta_part1.html" />
+    <link rel="next" title="Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests - Guidance for Industry and FDA Staff part 1" href="Diagnostic_part1.html" />
+    <link rel="prev" title="DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomized controlled trial part 1" href="Delta_part1.html" />
   <meta name="viewport" content="width=device-width, initial-scale=1"/>
   <meta name="docsearch:language" content="en"/>
   </head>
@@ -160,42 +160,44 @@
             </li>
         </ul>
         <ul class="current nav bd-sidenav">
-<li class="toctree-l1"><a class="reference internal" href="GCP_part1.html">Good Clinical Practice (GCP)</a></li>
+<li class="toctree-l1"><a class="reference internal" href="GCP_part1.html">Good Clinical Practice (GCP) part 1</a></li>
 
 
 
-<li class="toctree-l1"><a class="reference internal" href="GCP_part2.html">6. Clinical trial protocol and protocol amendment(s)</a></li>
+<li class="toctree-l1"><a class="reference internal" href="GCP_part2.html">Good Clinical Practice (GCP) part 2</a></li>
 
 
 
-<li class="toctree-l1"><a class="reference internal" href="E9_part1.html">1. INTRODUCTION</a></li>
 
+<li class="toctree-l1"><a class="reference internal" href="E9_part1.html">Guideline for Industry E9 Statistical Principles for Clinical Trials part 1</a></li>
 
 
-<li class="toctree-l1"><a class="reference internal" href="E9_part2.html">5. Data Analysis Considerations</a></li>
 
 
-<li class="toctree-l1"><a class="reference internal" href="Switching.html">Points to Consider on Switching between Superiority and Non-inferiority</a></li>
+<li class="toctree-l1"><a class="reference internal" href="E9_part2.html">Guideline for Industry E9 Statistical Principles for Clinical Trials part 2</a></li>
+
 
 
+<li class="toctree-l1"><a class="reference internal" href="Switching.html">Points to Consider on Switching between Superiority and Non-inferiority</a></li>
+
 
 
 
 
 
-<li class="toctree-l1"><a class="reference internal" href="Delta_part1.html"></a></li>
 
+<li class="toctree-l1"><a class="reference internal" href="Delta_part1.html">DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomized controlled trial part 1</a></li>
 <li class="toctree-l1 current active"><a class="current reference internal" href="#">DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomised controlled trial part2</a></li>
-<li class="toctree-l1"><a class="reference internal" href="Diagnostic_part1.html"></a></li>
-<li class="toctree-l1"><a class="reference internal" href="Diagnostic_part2.html"><strong><strong>Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests - Guidance for Industry and FDA Staff</strong></strong></a></li>
+<li class="toctree-l1"><a class="reference internal" href="Diagnostic_part1.html">Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests - Guidance for Industry and FDA Staff part 1</a></li>
+<li class="toctree-l1"><a class="reference internal" href="Diagnostic_part2.html">Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests - Guidance for Industry and FDA Staff part 2</a></li>
 
 
 
-<li class="toctree-l1"><a class="reference internal" href="E9R1_part1.html">E9(R1) STATISTICAL PRINCIPLES FOR CLINICAL TRIALS: ADDENDUM: ESTIMANDS AND SENSITIVITY ANALYSIS IN CLINICAL TRIALS</a></li>
+<li class="toctree-l1"><a class="reference internal" href="E9R1_part1.html">E9(R1) STATISTICAL PRINCIPLES FOR CLINICAL TRIALS: ADDENDUM: ESTIMANDS AND SENSITIVITY ANALYSIS IN CLINICAL TRIALS part 1</a></li>
 
 
 
-<li class="toctree-l1"><a class="reference internal" href="E9R1_part2.html">E9(R1) STATISTICAL PRINCIPLES FOR CLINICAL TRIALS: ADDENDUM: ESTIMANDS AND SENSITIVITY ANALYSIS IN CLINICAL TRIALS</a></li>
+<li class="toctree-l1"><a class="reference internal" href="E9R1_part2.html">E9(R1) STATISTICAL PRINCIPLES FOR CLINICAL TRIALS: ADDENDUM: ESTIMANDS AND SENSITIVITY ANALYSIS IN CLINICAL TRIALS part 2</a></li>
 
 
 
@@ -640,15 +642,15 @@ <h2>Discussion<a class="headerlink" href="#discussion" title="Permalink to this
       <i class="fa-solid fa-angle-left"></i>
       <div class="prev-next-info">
         <p class="prev-next-subtitle">previous</p>
-        <p class="prev-next-title"></p>
+        <p class="prev-next-title">DELTA2 guidance on choosing the target difference and undertaking and reporting the sample size calculation for a randomized controlled trial part 1</p>
       </div>
     </a>
     <a class="right-next"
        href="Diagnostic_part1.html"
        title="next page">
       <div class="prev-next-info">
         <p class="prev-next-subtitle">next</p>
-        <p class="prev-next-title"></p>
+        <p class="prev-next-title">Statistical Guidance on Reporting Results from Studies Evaluating Diagnostic Tests - Guidance for Industry and FDA Staff part 1</p>
       </div>
       <i class="fa-solid fa-angle-right"></i>
     </a>